NCT06287749View on ClinicalTrials.gov

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

RecruitingOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Pancreatic Cancer ResectablePancreatic Ductal AdenocarcinomaMinimal Residual DiseaseLiquid BiopsyctDNA
Interventions
BIOLOGICAL

Blood sample/Liquid Biopsy

ctDNA analysis

Trial Locations (1)

34295

RECRUITING

CHU de Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER